^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
Columvi (glofitamab-gxbm)
i
Other names: RG6026, RO7082859, CD20 TCB, RG 6026, RO-7082859, RO 7082859, anti-CD20 CD3 TCB, RG-6026
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Biogen, Roche
Drug class:
CD20 inhibitor, CD3 agonist
Related drugs:
